New Developments in Treatment for Bleeding Disorders – Novel Therapies
New panel discussion: New Developments in Treatment for Bleeding Disorders – Novel Therapies, is a cure for hemophilia around the corner? While clotting factor concentrates remain, by far, the mainstay of the management of hemophilia, a number of novel therapies under development have the potential to dramatically change the treatment landscape. Leading hematologists and patient […]
Expanding Access to Hemophilia Treatment Products
New panel discussion: Expanding Access to Hemophilia Treatment Products, what will be the game changer? While the WFH vision is “Treatment for All,” the majority of the world’s population has little to no access to hemophilia care. Patient advocates and WFH Humanitarian Aid and Public Policy representatives debate what might be the game changer in […]
Guide to National Tenders for the Purchase of Clotting Factor Concentrates
This guide explains how a national procurement system of factor concentrates can help to ensure that people with bleeding disorders have access to treatment which is not only sufficient in quantity, but also meets the required standards in relation to safety, efficacy, and quality. The second edition includes diverse case studies, discussion of prolonged half-life […]